News

CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company ...
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — The ...
Investing in ASX shares can be one of the best ways to grow your wealth over time. However, if you're new to the share market, it can also be very intimidating. The good news is that getting ...
The Eagles have a chance at redemption against the Chiefs in Super Bowl 59 — an opportunity that likely doesn't occur without Jalen Hurts. The fifth-year Philadelphia quarterback will have his ...
Their motto is Propter, Praemium Patienta (Patient for the sake of Reward) and was formed 80 years ago. It consists of volunteers and provides training for gliders in the Grob G104A aircraft ...
With the addition of a state-of-the-art MRI unit this fall and the college’s neurology services move from off-campus to the university, the CVM Animal Health Center is significantly advancing for ...
[From left to right] SB Finance Chief Business Officer, Gerard Betita, CVM Finance President and COO, Louie F. Nonesa, and SB Finance President and CEO, Abbie Dans-Casanova signed a partnership ...
A multi-center retrospective study on the efficacy and safety of regorafenib plus immune checkpoint inhibitors with or without TACE as a second-line treatment for advanced hepatocellular carcinoma.